Prospective Attitudes towards Respiratory Syncytial Virus (RSV) Vaccination: Validation of a Survey Instrument among Young Females in Jordan Pending Vaccine Authorization

In May 2023, the U.S. FDA advisors endorsed Pfizer’s pregnancy-administered vaccine (branded ABRYSVO) to protect infants from respiratory syncytial virus (RSV) infection. Vaccination can reduce the burden of RSV-related respiratory disease, with previous studies showing its substantial medical and f...

Descripción completa

Detalles Bibliográficos
Autores principales: Kherfan, Tleen, Sallam, Malik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459998/
https://www.ncbi.nlm.nih.gov/pubmed/37631954
http://dx.doi.org/10.3390/vaccines11081386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459998/
https://www.ncbi.nlm.nih.gov/pubmed/37631954
http://dx.doi.org/10.3390/vaccines11081386

Ejemplares similares